MHT: Timing is critical

Experts agree menopausal hormone therapy (MHT) is safe and effective for women with no absolute contraindications—but timing is critical Leading menopause experts have welcomed a UK study that suggests the risk between breast cancer and MHT is less than previously reported. A study published in the British Medical Journal (BMJ) found the most commonly prescribed

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Looking after your inventory
Next The week in review